Wearable Sensors in Cardiovascular Care

Photo by Luke Chesser on Unsplash

Why continuous heart monitoring matters

Clinicians often rely on snapshot data to make decisions about cardiovascular health. A patient might present with a normal heart rhythm in the clinic, while their underlying condition remains hidden during their daily routine. Wearable technology aims to close this gap by providing a stream of physiological data from outside the hospital. Understanding how these tools fit into clinical workflows is essential for anyone involved in modern patient management.

How researchers evaluated the current state of technology

This review article examines how wearable devices support cardiovascular care across three distinct stages: surveillance, diagnosis, and intervention. The authors categorised existing and emerging technologies, ranging from standard wearable electrocardiography and photoplethysmography to advanced tools like wearable ultrasound and seismocardiography. They also assessed how artificial intelligence processes large datasets to assist in risk stratification and disease detection.

Key findings on technology and clinical integration

The review highlights a shift from simple passive monitoring toward more complex systems, including closed-loop therapeutic devices. Key trends include the diversification of how sensors collect data and the growing reliance on sensor fusion, where multiple data streams are combined to provide a clearer picture of cardiovascular status. Artificial intelligence is increasingly used to turn these raw physiological measurements into actionable insights, such as monitoring heart failure status or blood pressure changes over time.

Implications for clinical practice

For clinicians and health informaticians, these developments suggest a future where patient management is more continuous rather than episodic. Integrating these devices into standard workflows could allow for earlier detection of issues and more personalised treatment plans. In resource-limited settings, the ability to monitor patients remotely might reduce the need for frequent travel to specialist centres. However, the success of this transition depends on how well these digital tools are woven into existing clinical decision-making processes.

Limitations and considerations

As this is a review article, its findings represent an expert synthesis of the field rather than primary clinical trial data. The authors identify several significant hurdles that remain before these technologies can be widely adopted. These include the need for rigorous validation of new sensors and the challenge of maintaining regulatory oversight as devices evolve. There are also persistent concerns regarding data privacy and the potential for these technologies to exacerbate existing health inequities. Until these issues are addressed, the transition from experimental use to standard clinical practice remains an ongoing process.

Reference

Tariq A, Sohn W, Lee YJ, Kim YS. Wearable Sensors and Remote Patient Monitoring in Cardiovascular Disease: From Continuous Physiological Surveillance to Actionable Insights. Arteriosclerosis, thrombosis, and vascular biology. 2026. doi:10.1161/atvbaha.126.324766. PMID: 42845242.

This research digest summarises a recently published article. It was drafted with AI assistance from the article's abstract and reviewed by the author before publication. Please read the original paper before relying on its findings.